CCO[C@@H]1OC(C(N)=O)=C[C@H](c2coc3ccccc3c2=O)[C@H]1CCCO
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?